About
AnnoGen develops proprietary gene expression engineering technologies, including the SuRE™ platform for designing bespoke promoters and enhancers, and the AIM™ platform for identifying optimal transgene integration sites, supporting applications in cell and gene therapy manufacturing as well as crop engineering.
Explore AnnoGen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.